AKT1 and diabetic retinopathy: Glucagon-like-peptide 1 receptor (GLP-1R) agonists, like liraglutide, can arrest retinal neurodegeneration promoted by hyperphosphorylated tau in a diabetic retinopathy model via activation of GLP-1R/Akt/GSK3β signaling [69].